Literature DB >> 17290663

Dually eligible enrollees: 2002.

Terry R Lied1.   

Abstract

Individuals eligible in both Medicaid and Medicare, the dually eligible enrollees, account for a disproportionate share of Medicaid utilization and payments. While comprising 14.7 percent of the Medicaid population, they accounted for 40.5 percent of Medicaid payments in 2002. Mean reimbursement for the dually eligible enrollees was nearly four times that of non-dually eligible Medicaid enrollees. This highlight examines utilization and payment data for the dually eligible enrollees in 2002.

Entities:  

Mesh:

Year:  2006        PMID: 17290663      PMCID: PMC4194962     

Source DB:  PubMed          Journal:  Health Care Financ Rev        ISSN: 0195-8631


Introduction

Dually-eligible enrollees, who are covered by Medicare and Medicaid, are among the most medically-vulnerable populations. They tend to be sicker, more depressed, and report more pain than Medicare-only eligible (Lied and Haffer, 2004). Not surprisingly, they tend to use more services than most other population groups. Table 1 compares per eligible payments of the dually eligible with non-dually eligible Medicaid enrollees based on an analysis of Federal fiscal year (FFY) 2002 Medicaid Statistical Information System (MSIS) data. The dually eligible enrollees accounted for $86.5 billion of the $213.5 billion in claims processing-based payments in FFY 2002 or 40.5 percent of total payments. Overall, 7.6 million dually eligible enrollees were enrolled for at least 1 month during FFY 2002, 14.7 percent of the total Medicaid eligible of 51.6 million individuals in FFY 2002.
Table 1

Medicaid Payments for Dually and Non-Dually Eligible Enrollees: Federal Fiscal Year 2002

ComparisonEnrolleeTotal

Dually EligibleNon-Dually Eligible
Overall
Total Payments (in Billions)$86.5$127.0$213.5
Total Eligibles (in Millions)7.643.951.6
Mean Payment for 2002$11,352$2,891$4,142
Selected Services1
Prescribed Drugs1,955307647
Nursing Facility4,514112762
Personal Support906193298
Home Health2624476
Inpatient367599565
ICF-MR87991207

Mean payment for 2002.

NOTE: ICF-MR is intermediate care facility for the mentally retarded.

SOURCE: Centers for Medicare & Medicaid Services: Data from the Medicaid Statistical Information System, 2002.

Figure 1 shows the mean Medicaid payments per dually and non-dually eligible enrollees for FFY 2002. The mean annual payment for the dually eligible enrollees was $11,352, almost four times that of the non-dually eligible enrollees at $2,891. Figure 2 compares Medicaid payments by selected service categories for the dually and non-dually eligible enrollees in FFY 2002. The dually eligible enrollees greatly exceeded their counterpart in nursing facility mean payments ($34.4 versus $4.8 billion). The dually eligible enrollees also experienced greater payments for drugs, intermediate care facility for the mentally retarded and home health services.
Figure 1

Mean Medicaid Payment Per Dually Eligible and Non-Dually Eligible Enrollees: Federal Fiscal Year 2002

Figure 2

Medicaid Payments for Dually Eligible and Non-Dually Eligible Enrollees, by Selected Service Categories: Federal Fiscal Year 2002

Figure 3 displays the mean Medicaid payment for the dually eligible enrollees broken down by State for FFY 2002 and clearly shows the large variation in mean payments among the States for this group of enrollees. Three States exceeded $20,000 in mean payments for the dually eligible enrollees: New York ($24,385), Connecticut ($22,127), and New Hampshire ($20,161).
Figure 3

Payments for Dually Eligible Medicaid Beneficiaries, by State: 2002

Total Medicaid payments for the dually eligible enrollees by selected age groupings are shown in Figure 4. The age groups 85 and over and 75-84 experienced the highest payment totals, $21.50 and $20.12 billion, respectively. The age group 65-74 at $13.99 billion was actually lower than the age group 45-64 at $18.15; however, the age group 65-74 has a range of 10 years compared to 20 for the age group 45-64. The age group 21-44 experienced $12.56 billion in payments, while the age group under 21 experienced $ 0.18 billion, or about $180 million in payments.
Figure 4

Medicaid Payments for Dually Eligible Enrollees, by Age: Federal Fiscal Year 2002

The aged and disabled account for over 99 percent of the payments for the dually eligible enrollees. Figure 5 shows that $48.89 billion was spent for the aged and $37.25 billion for the disabled compared to only about $20 million for children and $320 million for caretaker adults.
Figure 5

Medicaid Dually Eligible Enrollee Payments, by Basis of Eligibility: Federal Fiscal Year 2002

The recent passage and implementation of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 has increased the attention on prescribed drug costs in Medicaid. Figure 6 shows the Medicaid drug payments by category of dual eligibility. Qualified Medicaid beneficiaries with full Medicaid benefits experienced the highest amount of prescribed drug payments at $9 billion in FFY 2002.
Figure 6

Medicaid Drug Payments, by Dually Eligible Enrollee Category: Federal Fiscal Year 2002

  1 in total

1.  Health status of dually eligible beneficiaries in managed care plans.

Authors:  Terry R Lied; Samuel C Haffer
Journal:  Health Care Financ Rev       Date:  2004
  1 in total
  3 in total

1.  Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.

Authors:  Carolyn W Zhu; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

2.  Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries.

Authors:  Cathy J Bradley; Bassam Dahman; Paul M Bataki; Siran Koroukian
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

3.  The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study.

Authors:  Siran M Koroukian; Bassam Dahman; Glenn Copeland; Cathy J Bradley
Journal:  Health Serv Res       Date:  2009-10-15       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.